bims-ovdlit Biomed News
on Ovarian cancer: early diagnosis, liquid biopsy and therapy
Issue of 2022–03–06
four papers selected by
Lara Paracchini, Humanitas Research
  1. Cytoreductive Surgery for Relapsed Ovarian Cancer.
  2. Cytoreductive Surgery for Relapsed Ovarian Cancer. Reply.
  3. p53: an anticancer protein's chequered past and promising future.
  4. A visual guide to restoring the guardian of the genome.
  1. N Engl J Med. 2022 03 03. pii: 10.1056/NEJMc2120128#sa1. [Epub ahead of print]386(9): 896-897
    Cytoreductive Surgery for Relapsed Ovarian Cancer.
    Tomer Meirson, David Bomze, Gal Markel.
      
    DOI:  https://doi.org/10.1056/NEJMc2120128
  2. N Engl J Med. 2022 03 03. pii: 10.1056/NEJMc2120128#sa2. [Epub ahead of print]386(9): 897
    Cytoreductive Surgery for Relapsed Ovarian Cancer. Reply.
    Philipp Harter, Alexander Reuss, Andreas du Bois.
      
    DOI:  https://doi.org/10.1056/NEJMc2120128
  3. Nature. 2022 Mar;603(7899): S1
    p53: an anticancer protein's chequered past and promising future.
    Michael Eisenstein.
      
    Keywords:  Cancer; Medical research; Molecular biology
    DOI:  https://doi.org/10.1038/d41586-022-00565-x
  4. Nature. 2022 Mar;603(7899): S2-S3
    A visual guide to restoring the guardian of the genome.
    Michael Eisenstein.
      
    Keywords:  Cancer; Medical research; Molecular biology
    DOI:  https://doi.org/10.1038/d41586-022-00566-w
This page is being maintained by Thomas Krichel. It was last updated on 2024‒11‒22 at 4:26.